Literature DB >> 12796249

Phenotype of retinitis pigmentosa associated with the Ser50Thr mutation in the NRL gene.

David A R Bessant1, Graham E Holder, Frederick W Fitzke, Annette M Payne, Shomi S Bhattacharya, Alan C Bird.   

Abstract

BACKGROUND: We previously reported an Ser50Thr mutation in the NRL gene as a cause of autosomal dominant retinitis pigmentosa.
OBJECTIVE: To determine the characteristic features of the autosomal dominant retinitis pigmentosa phenotype associated with the NRL Ser50Thr mutation in affected individuals from 4 related families.
METHODS: Clinical records were available for 21 affected individuals; 7 underwent more extensive electrophysiologic and psychophysical testing.
RESULTS: Night blindness was the first symptom to manifest, with onset between birth and age 16 years. Difficulty with peripheral vision was experienced between 20 and 37 years of age. Visual acuity was well preserved in younger individuals, but those older than 30 years frequently had substantial visual loss (6/36 or worse) associated with macular atrophy. Electrophysiologic testing revealed a nondetectable scotopic electroretinogram with relative preservation of the photopic electroretinogram and pattern electroretinography in the 3 youngest patients tested (aged 15-18 years). In older individuals, all components of the electroretinogram were nondetectable. Dark-adapted visual fields in younger individuals were greatly impaired, but their photopic fields remained relatively well preserved. Older patients had photopic fields limited to just a few degrees. Distinctive peripapillary chorioretinal atrophy seems to develop as the disorder progresses.
CONCLUSIONS: The NRL Ser50Thr mutation is associated with selective loss of scotopic function before age 20 years. With time, however, the photopic system becomes affected, leading to loss of the photopic visual field and of visual acuity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796249     DOI: 10.1001/archopht.121.6.793

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Recessive NRL mutations in patients with clumped pigmentary retinal degeneration and relative preservation of blue cone function.

Authors:  Koji M Nishiguchi; James S Friedman; Michael A Sandberg; Anand Swaroop; Eliot L Berson; Thaddeus P Dryja
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-09       Impact factor: 11.205

2.  Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Andrea Sodi; Ilaria Passerini; Dario Giorgio; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-15       Impact factor: 3.117

3.  Recurrent mutation in the first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa.

Authors:  Frauke Coppieters; Bart P Leroy; Diane Beysen; Jan Hellemans; Karolien De Bosscher; Guy Haegeman; Kirsten Robberecht; Wim Wuyts; Paul J Coucke; Elfride De Baere
Journal:  Am J Hum Genet       Date:  2007-05-24       Impact factor: 11.025

4.  Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome.

Authors:  Karin W Littink; Patricia T Y Stappers; Frans C C Riemslag; Herman E Talsma; Maria M van Genderen; Frans P M Cremers; Rob W J Collin; L Ingeborgh van den Born
Journal:  Genes (Basel)       Date:  2018-01-30       Impact factor: 4.096

5.  Investigating cone photoreceptor development using patient-derived NRL null retinal organoids.

Authors:  Alyssa Kallman; Elizabeth E Capowski; Jie Wang; Aniruddha M Kaushik; Alex D Jansen; Kimberly L Edwards; Liben Chen; Cynthia A Berlinicke; M Joseph Phillips; Eric A Pierce; Jiang Qian; Tza-Huei Wang; David M Gamm; Donald J Zack
Journal:  Commun Biol       Date:  2020-02-21

6.  NRL-/- gene edited human embryonic stem cells generate rod-deficient retinal organoids enriched in S-cone-like photoreceptors.

Authors:  Elisa Cuevas; Daniel L Holder; Ashwak H Alshehri; Julie Tréguier; Jörn Lakowski; Jane C Sowden
Journal:  Stem Cells       Date:  2021-01-19       Impact factor: 5.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.